dexmethylphenidate chemical structure
Find information on thousands of medical conditions and prescription drugs.

Focalin

Dexmethylphenidate (commercially known as Focalin) is a pharmaceutical drug used to treat Attention Deficit Hyperactivity Disorder. It is very similar to Ritalin, but it only contains the d-isomer of methylphenidate. It is a stimulant that affects the central nervous system. Dexmethylphenidate is a short acting drug, its half-life usually being between four and six hours.

Home
Diseases
Medicines
A
B
C
D
E
F
Captagon
Famohexal
Famotidine
Faslodex
Faslodex
Fasoracetam
Felbamate
Felbatol
Felodipine
Felypressin
Femara
Femara
Fempatch
Femring
Fenfluramine
Fenofibrate
Fentanyl
Fexofenadine
Filgrastim
Filipin
Finasteride
Fioricet
Fiorinal
Flagyl
Flarex
Flavoxate
Flecainide
Flexeril
Flomax
Flonase
Flovent
Floxuridine
Fluacizine
Flucloxacillin
Fluconazole
Flucytosine
Fludarabine
Fludrocortisone
Flumazenil
Flunisolide
Flunitrazepam
Fluocinonide
Fluohexal
Fluorometholone
Fluorouracil
Fluoxetine
Fluphenazine
Flurazepam
Flutamide
Fluticasone
Fluvastatin
Fluvoxamine
FML
Focalin
Folic acid
Follutein
Fomepizole
Formoterol
Fortamet
Fortovase
Fosamax
Fosinopril
Fosinoprilat
Fosmidomycin
Fosphenytoin
Frova
Frovatriptan
Frusehexal
Fulvestrant
Fumagillin
Furazolidone
Furosemide
Furoxone
Fusafungine
Fusidic acid
Fuzeon
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]



Adult attention-deficit hyperactivity disorder
Adult attention-deficit hyperactivity disorder (ADHD) is the second most common neuropsychiatric disorder of adulthood, following depressive disorders; ...
invisible crisis: Women and psychiatric oppression, The
Women are by far the primary recipients of psychiatric "services," ana men are disproportionately the practitioners. Coercion and forced drug treatment ...
FDA Approved 16 Biologicals in 2001
The Food and Drug Administration (FDA) approved 16 new biotechnology based medicines and vaccines in 2001 and well as 8 new indications for previously ...
INVESTOR ALERTS for October 27, 2004
eLocity's velocity stocks to watch for today are: HEE Corporation (OTC: HCCF), Human Genome Sciences, Inc. (NASDAQ: HGSI), Onyx Pharmaceuticals, Inc.
Celgene Corporation Reports Record Operating Performance in Second Quarter With Strong Revenue and Profit Growth
-- Second Quarter Revenue Performance Driven by 36% Growth in THALOMID® Net Product Sales -- Quarterly Diluted Earnings Per Share Increased ...
New drugs, tools OKd to treat conditions
A number of new drugs and diagnostic tools recently have been approved, or are on the horizon, to treat attention deficit/ hyperactivity disorder. Adderall XR: This once-a-day version of Addera
CALBIOsummit 2003 Exhibitor Profiles
Business Editors/Biotechnology Writers CALBIOsummit 2003 SAN DIEGO--(BUSINESS WIRE)--March 7, 2003 The CALBIOsummit 2003 takes place next week, ...
Nationwide Survey of More Than 3,000 People Uncovers Gender Differences in ADHD
Nationwide Survey of More Than 3,000 People Uncovers Gender Differences in ADHD.

Home Contact Resources Exchange Links ebay